Ann: ResApp Announces SleepCheck, a Sleep Apnoea Screening App, page-445

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 445 Last

Share
Profile

Follow
AlCp

27,363 Posts.

1776

05/06/20

13:57

Post #: 45060816
Share

Originally posted by ChampKind01 ↑

Thanks, much appreciated.

Feel like there is substantial opportunity in this space and not just in the over 40's / 50's age group (providing the chosen business model and partnerships are correct).

The concept of OSA and associated health impacts are being discussed by younger adults these days too. Below is a link to a recent piece on the triple J Hack program (skip to a little over the half way point to get to the sleep study content).

it follows one of their journo's undertaking a sleep study.

Hope resapp / sleepcheck can help screen and subsequently have OSA diagnosed, without the need to go through the cumbersome sleep study process.

Further - hope the algorithm can eventually be trained to screen young children and infants. My daughter had large adenoids and tonsils which meant the first two years of her life where quite exhausting for both bubs and parents.

Once identified (which Sleepcheck could no doubt do (frequent snoring signature + breathing pauses + questions regarding night sweats, other symptoms etc.) = high risk *go see GP and/or ENT specialist regarding sleep apnea). She has been a new kid.

Screening could be done at key intervals during child development in a similar fashion to vaccinations, height, weight percentiles etc.

if diagnosis and intervention occurs early, then no doubt better health outcomes for child and parents and potentially better early childhood education outcomes for child.

Food for thought anyway.....

https://www.abc.net.au/triplej/programs/hack/hack/12245994

Expand

Not just diagnosis and intervention but only improvement, that's where an easy to use, convenient and cheap OSA screening device will be very useful for those OSA patients who have improved their diet and want to check if their AHI severity level have also improved to give them more encouragement to continue.

RAP Price at posting: 17.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ZER

Zeta Resources seeks to resolve the Panoramic takeover story

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

NAM

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

4DX

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 8 more messages in this thread...

First 445 Last

Add RAP (ASX) to my watchlist

Ann: ResApp Announces SleepCheck, a Sleep Apnoea Screening App, page-445

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Zeta Resources seeks to resolve the Panoramic takeover story

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

The market's shrugged at China's stimulus measures all year. Why is this one different?

The winners & losers on market if negative gearing were gone

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News